Connect with us

Technology

High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market Landscape – Technavio

Published

2 years ago

on

NEW YORK, Jan. 31, 2025 /PRNewswire/ — Report with market evolution powered by AI – The global high throughput screening (HTS) market size is estimated to grow by USD 19.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 12.12%  during the forecast period. Rise in R and D investments is driving market growth, with a trend towards increasing focus on promotional activities. However, shortage of trained healthcare professionals  poses a challenge. Key market players include Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

High Throughput Screening (HTS) Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 12.12%

Market growth 2024-2028

USD 19.9 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

11.64

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Japan, China, Germany, and France

Key companies profiled

Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.

Market Driver

High-throughput screening (HTS) is a key trend in the life sciences sector, particularly in the areas of drug discovery and research for complex illnesses like cancer and neurological disorders. HTS allows for the rapid testing of large compound libraries using automated equipment such as robotic arms and microplate readers. Data analytics plays a crucial role in HTS, with machine learning and data management systems used to analyze genomic data and chemical databases for target identification. Biotech startups and academic institutions are driving innovation in this field, with pharmaceutical corporations and research organizations collaborating to advance drug development. HTS is also used in stem cell research, toxicology, and open innovation models. HTS service providers offer instruments, software, and consumables to support this research. HTS is transforming the biopharmaceutical industry, enabling precision medicine and the repurposing of existing drugs for new indications. With advancements in technology, HTS is becoming more accessible to a wider range of organizations, including biotechnology startups and clinical trials. Despite these advancements, challenges remain, including false-positive findings and the need for specialized equipment maintenance. Overall, HTS is a vital tool in the global healthcare sector’s quest to develop new products and services for the detection and treatment of chronic diseases. 

The High Throughput Screening (HTS) market presents unique challenges for vendors due to its specialized nature and niche end-users. Brand and product visibility play a limited role in sales, and advertising and marketing are restricted. Key players in the industry recognize this issue and are promoting HTS through their websites and additional support materials. Thermo Fisher Scientific, for instance, provides explanatory documents, brochures, and interactive videos on YouTube to help end-users understand the technique better. Despite these efforts, there is a significant lack of awareness about HTS. Vendors must focus on improving their distribution networks to make these products readily available to end-users. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

High-throughput screening (HTS) is a crucial process in the biotechnology industry, enabling the rapid identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. The market for HTS is vast and diverse, with players including academic institutions, biotech startups, and pharmaceutical corporations. Challenges in this field include managing large data sets from compound libraries, dealing with false-positive findings, and maintaining specialized equipment. HTS involves the use of automation, robotics, and specialized instruments like microplate readers and high-resolution imaging systems. Data analytics is essential for making sense of the vast amounts of data generated. Machine learning and data management systems help in data organization, retrieval, integration, and storage. HTS is not just limited to pharmaceutical companies but also extends to the global healthcare sector, research organizations, and contract research organizations. Collaborative networks and HTS service providers play a significant role in driving innovation through open innovation models. HTS is also used in stem cell research, toxicology, and drug development. HTS involves various techniques like cell-based assays, lab-on-a-chip, and label-free technology. Biochemical screening and target identification are critical components of the HTS process. Drug repurposing initiatives, such as those from Relay Therapeutics, are gaining popularity in the biopharmaceutical industry due to their potential to bring new drugs to market faster and more cost-effectively. The HTS market is expected to grow significantly due to the increasing focus on precision medicine and the need for new drugs to address chronic diseases. Consumables, software, and services are essential products and services in the HTS market. The use of technology in HTS, such as automation and advanced detection techniques, is transforming the drug discovery process. Despite the challenges, the future of HTS looks promising, with advancements in technology and a growing focus on collaboration and open innovation models. The use of HTS in drug discovery and development is expected to revolutionize the way we approach complex illnesses and bring new treatments to market.In today’s fast-paced pharmaceutical and biotechnology industries, High Throughput Screening (HTS) has become a crucial tool for discovering new drugs and optimizing existing ones. However, the successful implementation of HTS relies heavily on the availability of skilled personnel. The shortage of trained professionals in this field can lead to non-compliance and improper screening of drug targets. Consequently, product failures and regulatory issues can result in significant financial losses for companies. This issue is particularly prevalent in developing countries, where the healthcare system lacks the necessary workforce to effectively utilize HTS technology. To mitigate this challenge, it is essential for organizations to invest in training and development programs for their staff, ensuring they have the necessary expertise to operate HTS equipment effectively and efficiently.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This high throughput screening (HTS) market report extensively covers market segmentation by  

Application 1.1 Target identification and validation1.2 Primary and secondary screening1.3 Toxicology assessment1.4 Stem cell researchEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 Academic and research institutes2.3 CROsGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Target identification and validation-  The global high throughput screening (HTS) market is driven by the increasing need for target identification and validation in drug development. This process involves finding potential therapeutic targets for diseases or conditions without existing treatments or inadequate current options. Early and thorough target identification and validation establish a strong link to clinical trial success. Chronic diseases like cardiovascular diseases, cancer, and respiratory diseases, which have a high global prevalence, fuel the demand for new targets. Additionally, the growing pipeline for biological candidates, outsourcing from pharmaceutical companies, and regulatory agencies’ demand for accurate drug and process development details contribute to market expansion. Advanced bioinformatics tools, automated experimental designs, and AI/ML algorithms are enhancing target identification and validation, further boosting the segment’s growth. Consequently, these factors are expected to fuel the growth of the target identification and validation segment in the global high throughput screening market during the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

High-throughput screening (HTS) is a critical technology in the global healthcare sector, enabling the rapid and efficient identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. HTS utilizes compound libraries, often containing hundreds of thousands to millions of compounds, which are screened against disease targets using automated systems. These systems include robotic arms, microplate readers, and high-resolution imaging systems. Data analytics plays a crucial role in HTS, with data management systems, data storage, data organization, data retrieval, data integration, and chemical databases essential for processing and interpreting the vast amounts of data generated. Academic institutions, biotech startups, research organizations, and pharmaceutical corporations all contribute to the HTS market, with open innovation models facilitating collaboration and knowledge sharing. Drug repurposing, the process of discovering new uses for existing drugs, is also a significant application of HTS. The market for HTS is expected to grow significantly due to the increasing demand for new and effective treatments for various diseases.

Market Research Overview

High Throughput Screening (HTS) is a critical technology in the life sciences sector, enabling the rapid identification of potential drug candidates for complex illnesses such as cancer and neurological disorders. HTS utilizes compound libraries, automation, and specialized equipment like robotic arms, microplate readers, and high-resolution imaging systems to screen large numbers of compounds against specific targets. Data analytics plays a crucial role in HTS, with machine learning and data management systems used to organize, store, retrieve, integrate, and analyze genomic data and chemical databases. Collaborative networks and HTS service providers facilitate open innovation models and knowledge sharing among academic institutions, biotech startups, pharmaceutical corporations, and research organizations. Drug repurposing initiatives and biopharmaceutical industry leaders are leveraging HTS for precision medicine and target identification, while toxicology and stem cell research also benefit from this technology. The global healthcare sector continues to invest in HTS for drug discovery, clinical trials, and product development, driving the market for instruments, software, and consumables.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationTarget Identification And ValidationPrimary And Secondary ScreeningToxicology AssessmentStem Cell ResearchEnd-userPharmaceutical And Biotechnology CompaniesAcademic And Research InstitutesCROsGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-throughput-screening-hts-market-to-grow-by-usd-19-9-billion-2024-2028-boosted-by-rising-rd-investments-with-ai-redefining-market-landscape—technavio-302364447.html

SOURCE Technavio

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Flō Networks Announces Intention to Launch Public Tender Offers to Acquire Up to 100% of Controladora Axtel, S.A.B. de C.V. and Axtel, S.A.B. de C.V.

Published

2 minutes ago

on

September 1, 2026

By

MEXICO CITY and EL PASO, Texas, Sept. 1, 2026 /CNW/ — Transtelco Holding, Inc. (doing business as Flō Networks, or “Flō”), a U.S.-based, independent digital infrastructure provider operating its own fiber-optic network across Mexico, the Southwestern United States and Latin America, today announced its intention to launch concurrent public tender offers (ofertas públicas de adquisición, or the “Offers”) to acquire up to 100% of the outstanding shares of Controladora Axtel, S.A.B. de C.V. (“Controladora Axtel”) and up to 100% of the outstanding CPOs of Axtel, S.A.B. de C.V. (“Axtel,” and together with Controladora Axtel, the “Axtel Companies”).

Flō has received preliminary approval from the Boards of Directors of both Axtel Companies to continue the process

Flō has received preliminary approval from the Boards of Directors of both Axtel Companies to continue the process toward launching the Offers, and is working to obtain the required regulatory approvals.

The commencement of the Offers remains subject to authorization by the Comisión Nacional Bancaria y de Valores, clearance by the Comisión Nacional Antimonopolio, the receipt of any other required regulatory approvals, and the satisfaction of the applicable contractual and corporate conditions. Subject to the satisfaction of these requirements, Flō is prepared to move promptly toward commencement of the Offers. The terms and conditions of the Offers, including the applicable offering documents, will be published in accordance with Mexican securities laws and the regulations of the Bolsa Mexicana de Valores at the appropriate time.

“This is an important step in our long-term vision for Flō and for the digital infrastructure that will support Mexico’s continued economic and technological development,” said Miguel Fernandez, Chief Executive Officer of Flō Networks. “By bringing together the complementary networks, capabilities and talent of Flō and Axtel, we have an opportunity to create a stronger digital infrastructure platform with greater scale, reach and capacity to serve customers across Mexico and beyond. We believe that stronger infrastructure enables stronger businesses, greater innovation and new opportunities for the communities and economies we connect.”

The proposed acquisition would combine complementary assets and expertise to strengthen Flō’s ability to invest in network resilience, expand its portfolio of digital services and deliver greater value to businesses operating in Mexico and across the region. Flō believes the combination would create meaningful operational and commercial synergies while supporting continued investment in the infrastructure required for critical technologies for productivity and competitiveness. The transaction would also create opportunities for long-term value creation for customers, employees, shareholders, partners and the communities the companies serve.

About Flō Networks

Founded as Transtelco in 2001, Flō Networks is a leading digital infrastructure provider connecting companies on both sides of the U.S.-Mexico border and across the Americas. Flō provides comprehensive connectivity solutions and advanced cloud infrastructure to Fortune 500 companies, telecommunications providers and cable operators through a fiber-optic network spanning more than 30,000 route miles across the Southwestern United States and Mexico, with connectivity across fifteen countries throughout the Americas. For more information, visit flo.net.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fl-networks-announces-intention-to-launch-public-tender-offers-to-acquire-up-to-100-of-controladora-axtel-sab-de-cv-and-axtel-sab-de-cv-302866536.html

SOURCE Flō Networks

Continue Reading

Technology

Arista Demand Hires Jordanna Howard to Strengthen the Company’s Continued Growth

Published

2 minutes ago

on

September 1, 2026

By

SAN FRANCISCO, Sept. 1, 2026 /PRNewswire/ — Arista Demand, a leading provider of B2B demand generation solutions, is pleased to announce Jordanna Howard has joined the company as VP, Global Integrated Sales, effective September 1, 2026.

Prior to joining Arista Demand, Jordanna spent five years at Veritas Media Group, serving as VP of Client Services. Jordanna played a key part in growing VMG’s client portfolio and driving net-new revenue through new business partnerships, while also expanding and strengthening existing client relationships. She was instrumental in championing VMG’s reputation for white-glove service, exceptional client experiences, and long-term client success.

Jordanna joins Arista Demand as the organization continues to expand its capabilities, strengthen and build client partnerships, and help B2B organizations connect with the right prospects through results-driven demand generation and media initiatives.

“We are thrilled to welcome Jordanna to Arista Demand,” said Managing Director, Jennifer Sand. “She brings tremendous experience, energy, and a client-focused approach that aligns perfectly with how we work. Jordanna will be an important part of our continued growth, and we’re excited to have her on the team.”

In her new role, Jordanna will focus on client development, partnerships, and sales. Her experience in digital and non-traditional media will further strengthen Arista Demand’s ability to deliver innovative and integrated, measurable solutions, beyond lead gen, for clients.

“I’m excited to join Arista Demand and become part of a team that is so focused on its clients and their success,” said Howard. “I look forward to contributing to the company’s growth and helping our clients achieve meaningful results.”

Jordanna lives in Napa, California, with her partner, Jeff, and daughter, Mackie. Outside of work, she loves spending time with family and friends and is passionate about giving back.

She serves on UCSF’s Board of Directors for “All May See” vision foundation as well as sfBIG’s Board, supporting and connecting the Bay Area advertising community. Jordanna is also actively involved in her daughter’s school and is the troop leader for her local Girl Scouts Brownie troop.

About Arista Demand

Arista Demand helps B2B organizations accelerate revenue through intent targeted demand generation programs designed to connect brands with their respective audience that matter most. Through a combination of intent, 1st party data, strategy, technology, and client-focused execution, Arista Demand helps marketers build pipeline and drive measurable business results. Arista Demand brings buyers and sellers together around the globe. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/arista-demand-hires-jordanna-howard-to-strengthen-the-companys-continued-growth-302865498.html

SOURCE Arista Demand

Continue Reading

Technology

Reducto Unveils a Frontier Parsing Model That Makes the World’s Hardest Documents AI-Ready for 1¢ a Page

Published

2 minutes ago

on

September 1, 2026

By

The new r-1 model is the first in a family of document intelligence models that reduces parsing errors by up to 20% while replacing complex, multi-tool pipelines with a single model that costs up to 6× less.

SAN FRANCISCO, Sept. 1, 2026 /PRNewswire/ — Reducto today introduced r-1, a frontier document parsing model that turns complex PDFs, scans, spreadsheets, and other files into accurate, structured data for AI systems.

Reducto has already established itself as a leader in document parsing by handling the long tail of complex files that break conventional tools. Available today in preview, r-1 extends that lead—reducing errors by up to 20%, improving latency at high volumes, and bringing the all-in cost down to 1¢ per page.

Before an AI system can reason over a document, it must first understand what is on the page. That becomes difficult when meaning is encoded not only in text, but also in tables, handwriting, reading order, formatting, checkboxes, strikethroughs, and the position of content. A parser that misreads a financial table can give an AI agent the wrong numbers. One that drops a strikethrough can reverse the meaning of a contract.

Established services such as Amazon Textract and Azure Document Intelligence helped make cloud document processing widely available. But organizations working with complex documents often still combine multiple tools, models, and layers of post-processing to achieve the accuracy they need. In Reducto’s evaluations, r-1 outperformed commonly used hyper-scaler products and large LLMs on complex documents while providing a complete parse at one all-in price.

Built from the ground up and trained on some of the most challenging document data in the world, r-1 combines layout detection, reading order, tables, formatting, grounding, and granular citations in a single model. It is designed for the long tail of documents where simpler parsers break down, including dense tables, unusual layouts, low-quality scans, handwriting, watermarked content, and files that do not follow predictable templates.

By combining these capabilities, r-1 can handle an organization’s full document workload without requiring teams to route files among providers or maintain separate pipelines for different document types. Its flat price of 1¢ per page includes the complete parse, without additional model charges or feature-based multipliers.

r-1 is the first in a broader family of Reducto parsing models designed for different points on the accuracy, latency, and cost curve. Planned additions include r-1 mini, a smaller model for speed- and cost-sensitive workloads, and automatic routing that selects the right model for each page.

Organizations using another parser can receive up to $5,000 in credits to test r-1 on their most difficult documents, along with hands-on benchmarking support, at reducto.ai/migrate. r-1 is also available today in preview through a configuration flag in the Reducto Parse API.

About Reducto

Reducto is an agentic document platform that turns complex, real-world documents into structured data for AI agents and document-intensive workflows. The company has raised more than $108 million from investors including Andreessen Horowitz and First Round Capital and has processed more than a billion pages a month. Its customers include Harvey, Scale AI, Vanta, Airtable, Toast, and Fortune 10 enterprises.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/reducto-unveils-a-frontier-parsing-model-that-makes-the-worlds-hardest-documents-ai-ready-for-1-a-page-302866077.html

SOURCE Reducto

Continue Reading

Trending